TITLE:
Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)

CONDITION:
Heart Failure

INTERVENTION:
Losartan 50 mg

SUMMARY:

      This is a multicenter study to evaluate potential decrease in hospitalization events and
      time between events and increasing longevity in patients with symptomatic congestive heart
      failure and intolerant of first-line medication for heart failure. This study will evaluate
      if higher doses of the investigational drug given daily will be superior to the lower dose
      of the same investigational drug given daily.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Symptomatic heart failure with known or recently diagnosed intolerance of treatment
             with first-line medication for heart failure

          -  May or may not be receiving an alternative and/or additional drug treatment
      
